Skip to content
HowShorted

Sarepta Therapeutics, Inc. short interest in 2026

In 2026, Sarepta Therapeutics, Inc.'s disclosed short interest ran from 20.31% of shares outstanding on 15 Jan 2026 to 24.08% on 15 Sep 2026, a change of +3.77 percentage points. The year's high was 27.22% on 30 Jun 2026 and its low 20.27% on 27 Feb 2026, averaging 23.64% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.47 days on 15 Apr 2026. Full history: Sarepta Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Sarepta Therapeutics, Inc. in 2026

2026 in figures

Start of year
20.31% (15 Jan 2026)
End of year
24.08% (15 Sep 2026)
Change
+3.77 pp
High
27.22% (30 Jun 2026)
Low
20.27% (27 Feb 2026)
Average
23.64%
Highest days to cover
11.47 (15 Apr 2026)
SEC filings marked
7

Every report in 2026

Sarepta Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202620.31%6.50results (8-K)
30 Jan 202621.21%7.40
13 Feb 202621.18%9.39
27 Feb 202620.27%9.82results (8-K)
13 Mar 202621.84%9.1010-K filed
31 Mar 202624.55%6.26
15 Apr 202624.18%11.47
30 Apr 202623.78%9.54
15 May 202623.70%7.3210-Q filed, results (8-K)
29 May 202623.80%9.44
15 Jun 202623.84%9.10
30 Jun 202627.22%5.75
15 Jul 202626.98%9.22
31 Jul 202626.10%8.77
14 Aug 202625.61%9.0710-Q filed, results (8-K)
31 Aug 202623.31%8.46
15 Sep 202624.08%8.02

See also: Sarepta Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.